RE-BVS – Piemonte Repository

Sfoglia per RIVISTA
PHARMACEUTICALS (BASEL, SWITZERLAND)
Collezione ASL Città di Torino

Items : 8

A Novel UHPLC-MS/MS Method for the Quantification of Seven Opioids in Different Human Tissues. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2023 Jun 19;16(6):903. doi: 10.3390/ph16060903.

2023
ASL Città di Torino

Manca A; De Nicolò A; De Vivo ED; Ferrara M; Oh S; Khalili S; Higgins N; Deiss RG; Bonora S; Cusato J; Palermiti A; Mula J; Gianella S; D'Avolio A;

Antifungal Drug Plasma Exposures: A Possible Contribution of Vitamin D-Related Gene Variants. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2022 May 20;15(5):630. doi: 10.3390/ph15050630.

2022
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Calcagno A; Rosa FG; Chiara F; Di Perri G; Allegra S; De Francia S; De Nicolò A; Antonucci M; Manca A; Mula J; Palermiti A; Cusato J;

Factors Influencing the Intracellular Concentrations of the Sofosbuvir Metabolite GS-331007 (in PBMCs) at 30 Days of Therapy. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2022 Mar 15;15(3):355. doi: 10.3390/ph15030355.

2022
ASL Città di Torino

Cusato J; Boglione L; De Nicolò A; Caviglia GP; Mornese Pinna S; Ciancio A; Troshina G; Smedile A; Antonucci M; Avataneo V; Palermiti A; Mula J; Manca A; Cariti G; Cantù M; Saracco GM; Di Perri G; D'Avolio A;

Vitamin D-Related Genetics as Predictive Biomarker of Clinical Remission in Adalimumab-Treated Patients Affected by Crohn's Disease: A Pilot Study. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2021 Nov 27;14(12):1230. doi: 10.3390/ph14121230.

2021
ASL Città di Torino

Ribaldone DG; Zanzi F; Astegiano M; Ceccarelli L; Costa F; Mula J; Massano A; Mangia M; Dibitetto S; Caviglia GP; Tomasello C; Bertani L; Antonucci M; D'Avolio A; Cusato J;

Analysis of Cannabinoids Concentration in Cannabis Oil Galenic Preparations: Harmonization between Three Laboratories in Northern Italy. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2021 May 14;14(5):462. doi: 10.3390/ph14050462.

2021
ASL Città di Torino

Palermiti A; Cafaro A; Barco S; Bucchioni P; Franceschini P; Cusato J; De Nicolò A; Manca A; De Vivo ED; Russo E; Cecchi F; Pigliasco F; Lillo F; Tripodi G; D'Avolio A; Cangemi G;

Development and Validation of an Up-to-Date Highly Sensitive UHPLC-MS/MS Method for the Simultaneous Quantification of Current Anti-HIV Nucleoside Analogues in Human Plasma. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2021 May 13;14(5):460. doi: 10.3390/ph14050460.

2021
ASL Città di Torino

De Nicolò A; Manca A; Ianniello A; Palermiti A; Calcagno A; Ferrara M; Antonucci M; Cusato J; Avataneo V; De Vivo E; Bonora S; De Rosa FG; Di Perri G; D'Avolio A;

Cannabis-Based Oral Formulations for Medical Purposes: Preparation, Quality and Stability. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2021 Feb 22;14(2):171. doi: 10.3390/ph14020171.

2021
ASL Città di Torino
AOU Città della Salute di Torino

Brusa P; De Luca A; Collino M; Ravetto Enri L; Torta R; D'Avolio A; Pignata I; Simiele M; Baratta F;

Validation of a UHPLC-MS/MS Method to Quantify Twelve Antiretroviral Drugs within Peripheral Blood Mononuclear Cells from People Living with HIV. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2020 Dec 25;14(1):12. doi: 10.3390/ph14010012.

2020
ASL Città di Torino

De Nicolò A; Ianniello A; Ferrara M; Avataneo V; Cusato J; Antonucci M; De Vivo E; Waitt C; Calcagno A; Trentalange A; Muccioli G; Bonora S; Di Perri G; D'Avolio A;